May 25, 2024
You are here:  Home  >  Health Care & Life Science  >  Current Article

SEC charges Sientra, ex-CEO Zeini with misleading investors


Breast implant manufacturer Sientra’s headquarters in Goleta. The Securities and Exchange Commission has charged Goleta breast implant maker Sientra and its former CEO Hani Zeini with misleading investors in a 2015 stock offering that netted the company gross proceeds of $66 million. The company agreed to settle the charges without admitting or denying the findings,…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.